COMMUNIQUÉS West-GlobeNewswire

-
Cogent Biosciences to Present SUMMIT Part 1b Data with Bezuclastinib in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2024 AAAAI Annual Meeting
05/02/2024 -
Spectral AI Announces Publication of Letter to Shareholders
05/02/2024 -
Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, and Innovative Therapeutics through a Systems Biology Approach
05/02/2024 -
Curia reçoit le CDMO Leadership Award 2024
05/02/2024 -
Intelligent Bio Solutions Inc. Announces Exercise of Previously Issued Warrants for $1.77 Million in Gross Proceeds
05/02/2024 -
Researchers at KFSH&RC & KAUST Discover Gene Responsible for Reproduction of the Most Dangerous Malaria Strain
05/02/2024 -
MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product
05/02/2024 -
Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent
05/02/2024 -
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
05/02/2024 -
eFFECTOR Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
05/02/2024 -
Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
05/02/2024 -
Chiesi Global Rare Diseases Announces Health Canada Approval of MYALEPTA™ (metreleptin for injection) for the Treatment of Patients with Lipodystrophy
05/02/2024 -
Uncle Bud’s to Launch New Premium Health and Wellness Products Leveraging Pressure BioSciences UltraShear Processing for Revolutionary Product Effectiveness
05/02/2024 -
Celldex Announces Upcoming Presentation of Barzolvolimab Phase 2 Results in Chronic Spontaneous Urticaria at AAAAI 2024
05/02/2024 -
Mesa Labs Announces Third Quarter Results
05/02/2024 -
Jasper Therapeutics Announces Preclinical Data Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
05/02/2024 -
MediWound to Participate in Two Upcoming Investor Conferences
05/02/2024 -
ORYZON to Provide Corporate Progress Updates at Several Events in February-March
05/02/2024 -
Ocuphire Pharma Announces Presentation on APX3330 at the Annual Angiogenesis, Exudation, and Degeneration 2024 Conference
05/02/2024
Pages